Why Does Motilal Oswal Expect More Upside in SRF?
About the Brokerage View
Motilal Oswal has reaffirmed its Buy recommendation on SRF with a target price of ₹3,350. The brokerage believes the company's next growth cycle will be driven by record performance in its fluorochemicals business, significant investments in next-generation refrigerants and an expected recovery in specialty chemicals.
Despite temporary weakness in agrochemical-linked demand affecting the specialty chemicals segment, Motilal Oswal expects earnings momentum to strengthen from FY27 as demand gradually improves.
SRF continues to strengthen its position across high-value specialty chemicals and fluorochemicals. The company's investment strategy reflects confidence in long-term demand for environmentally friendly refrigerants and advanced chemical products.
Key Highlights
🔹 Motilal Oswal maintains a Buy rating.
🔹 Target Price: ₹3,350.
🔹 Fluorochemicals revenue grew nearly 60% during FY26.
🔹 ₹23 billion capex planned for next-generation HFO refrigerants.
🔹 Specialty Chemicals recovery expected from FY27.
🔹 EBITDA margin improved to 22.8%.
🔹 Profit after tax increased 49% year-on-year to ₹20.4 billion.
🔹 Brokerage expects approximately 22% PAT CAGR through FY28.
🔹 FY28 EPS estimated at around ₹101.
Investors seeking broader market opportunities may also monitor Nifty Tip insights for overall market direction.
Motilal Oswal Investment Snapshot
| Parameter | Brokerage View |
|---|---|
| Recommendation | Buy |
| Target Price | ₹3,350 |
| Fluorochemicals Growth | 60% Revenue Growth |
| HFO Capex | ₹23 Billion |
| EBITDA Margin | 22.8% |
| Expected PAT CAGR | 22% Through FY28 |
According to Motilal Oswal, SRF's strong balance between capacity expansion, profitability improvement and specialty product development supports its long-term investment case.
Strengths & Weaknesses
|
Strengths
🔹 Strong fluorochemicals growth. 🔹 Improving operating margins. 🔹 Large HFO investment pipeline. 🔹 Healthy earnings visibility. |
Weaknesses
🔹 Specialty chemicals demand remains soft. 🔹 Agrochemical slowdown. 🔹 Capital-intensive expansion. 🔹 Commodity price sensitivity. |
The company's diversified business mix continues to reduce dependence on any single segment while supporting long-term earnings resilience.
Opportunities & Threats
|
Opportunities
🔹 Growing HFO refrigerant demand. 🔹 Specialty chemicals recovery. 🔹 Capacity expansion benefits. 🔹 Export market opportunities. |
Threats
🔹 Global demand slowdown. 🔹 Raw material volatility. 🔹 Project execution delays. 🔹 Competitive pricing pressure. |
Execution of the HFO expansion project and recovery in specialty chemicals will remain key variables influencing SRF's earnings trajectory over the next few years.
Valuation & Investment View
Motilal Oswal believes SRF offers an attractive risk-reward profile, trading at around 27 times estimated FY28 earnings despite expectations of approximately 22% profit CAGR through FY28. Continued investment in advanced fluorochemicals and improving specialty chemicals demand could support long-term value creation.
Investors may also follow BankNifty Tip updates for broader market insights.
Investor Takeaway
Derivative Pro & Nifty Expert Gulshan Khera, CFP®, observes that SRF's combination of capacity expansion, improving profitability and long-term fluorochemicals demand strengthens its investment case. Investors should monitor execution of new projects and the expected recovery in specialty chemicals while evaluating the company's long-term growth potential. Explore more market insights at Indian-Share-Tips.com.
Related Queries on SRF and Specialty Chemicals
🔹 Why is Motilal Oswal bullish on SRF?
🔹 What is driving SRF's fluorochemicals growth?
🔹 What are HFO refrigerants?
🔹 Why is specialty chemicals recovery expected from FY27?
🔹 How does SRF's valuation compare with future earnings growth?
SEBI Disclaimer: This article is for educational and informational purposes only and should not be construed as investment advice. Investors should consult their financial advisor before making investment decisions.









Join 12,86,317 Smart Traders. Enter Email for Free Stock Tips. Instant Activation.
